T
Todd E. DeFor
Researcher at University of Minnesota
Publications - 297
Citations - 19625
Todd E. DeFor is an academic researcher from University of Minnesota. The author has contributed to research in topics: Transplantation & Hematopoietic stem cell transplantation. The author has an hindex of 64, co-authored 288 publications receiving 17856 citations. Previous affiliations of Todd E. DeFor include City of Hope National Medical Center.
Papers
More filters
Journal ArticleDOI
32: Single versus double umbilical cord blood transplantation (UCBT): Higher risk of acute graft-versus-host disease (GVHD) but lower transplant related mortality (TRM) in recipients of double UCBT
Margaret L. MacMillan,Claudio G. Brunstein,Todd E. DeFor,Bruce R. Blazar,Daniel J. Weisdorf,John E. Wagner +5 more
Journal ArticleDOI
Sirolimus/Mycophenolate Mofetil (MMF): Effective Calcineurin Inhibitor-Free GVHD Prophylaxis for Reduced Intensity Conditioning (RIC) Umbilical Cord Blood (UCB) Transplantation
Nelli Bejanyan,John Rogosheske,Todd E. DeFor,Shernan G. Holtan,Pamala A. Jacobson,Margaret L. MacMillan,Michael R. Verneris,Mukta Arora,Aleksandr Lazaryan,Bruce R. Blazar,Daniel J. Weisdorf,John E. Wagner,Claudio G. Brunstein +12 more
Journal ArticleDOI
HCT related toxicities and mortality in frail recipients.
Merve Pamukcuoglu,Smita Bhatia,Daniel J. Weisdorf,Todd E. DeFor,Celalettin Ustun,Manju Nayar,Shernan G. Holtan,Najla El Jurdi,Bharat Thyagarajan,Claudio G. Brunstein,Veronika Bachanova,Erica D. Warlick,Mukta Arora +12 more
TL;DR: A large number of patients with cancer are at high risk of developingFrailty is a state characterized by diminished physiological reserve and increased vulnerability to stress, and adversely affects outcomes in older patients withcancer.
Journal ArticleDOI
The Effect of Measurable Residual Disease at the Time of Allogeneic Hematopoietic Cell Transplantation on Outcomes in Patients with Acute Myeloid Leukemia: A Meta-Analysis
Sarah A. Buckley,Brent L. Wood,Megan Othus,Christopher S. Hourigan,Celalettin Ustun,Michael A. Linden,Todd E. DeFor,Michele Malagola,Christopher G. Kanakry,Christopher G. Kanakry,Bernd Gruhn,Beth Devine,Roland B. Walter +12 more
TL;DR: Across all studies, MRD+ status prior to HCT is associated with an increased risk of relapse and shorter LFS and OS, whereas there is no association with NRM.
Journal ArticleDOI
TU‐E‐ValB‐01: Helical Tomotherapy Targeting Total Bone Marrow ‐ Initial Clinical Experience at the University of Minnesota
S Hui,Michael R. Verneris,Patrick D. Higgins,Bruce J. Gerbi,Brenda J. Weigel,Scott T. Baker,C Fraser,M. Tomblyn,Anna Petryk,Todd E. DeFor,Kathryn E. Dusenbery +10 more
TL;DR: The successful use of Tomotherapy at delivering intensity modulated radiotherapy to the bone and bone marrow spaces along the entire axis of a patient and a dosimetric analysis of the total marrow irradiation (TMI) treatment are reported.